Over het archief
Het OWA, het open archief van het Waterbouwkundig Laboratorium heeft tot doel alle vrij toegankelijke onderzoeksresultaten van dit instituut in digitale vorm aan te bieden. Op die manier wil het de zichtbaarheid, verspreiding en gebruik van deze onderzoeksresultaten, alsook de wetenschappelijke communicatie maximaal bevorderen.
Dit archief wordt uitgebouwd en beheerd volgens de principes van de Open Access Movement, en het daaruit ontstane Open Archives Initiative.
Basisinformatie over ‘Open Access to scholarly information'.
| one publication added to basket [344761] |
Development of marine oligosaccharides for potential wound healing biomaterials engineering
Jafari, H.; Delporte, C.; Bernaerts, K.V.; De Leener, G.; Luhmer, M.; Nie, L.; Shavandi, A. (2021). Development of marine oligosaccharides for potential wound healing biomaterials engineering. Chemical Engineering Journal Advances 7: 100113. https://dx.doi.org/10.1016/j.ceja.2021.100113
In: Chemical Engineering Journal Advances. Elsevier: Amsterdam. e-ISSN 2666-8211, meer
|   |
| Trefwoord |
|
| Author keywords |
Chitooligosaccharide (CHOS); Chitosan degradation; Microwave irradiation; Antioxidant activity; Antibacterial activity; Wound healing |
| Auteurs | | Top |
- Jafari, H., meer
- Delporte, C.
- Bernaerts, K.V.
- De Leener, G.
|
- Luhmer, M.
- Nie, L.
- Shavandi, A., meer
|
|
| Abstract |
This study aims to investigate the oxidative degradation of chitosan to produce chitooligosaccharides (CHOS) as a potential bioagent for biomaterials engineering. CHOS was produced via microwaved-assisted oxidative degradation of chitosan by using hydrogen peroxide in an acidic aqueous solution. The effects of the H2O2 concentration, reaction time, microwave power, and reaction temperature on the degradation of chitosan were investigated. Following optimization of these parameters, three soluble CHOS fractions CHOS 1 (4-8 kDa), CHOS 2 (3-5 kDa), and CHOS 3 (1-3 kDa) were synthesized and the physicochemical, structural, thermal properties and water solubility were investigated. No significant structure alteration of the initial chitosan was detected by Fourier transform infrared spectroscopy (FTIR), UV–vis, and nuclear magnetic resonance (NMR) analyses, making our microwave-assisted oxidative degradation a valuable method for the production of CHOS. Interestingly, CHOS fractions exhibited improved radical scavenging activities and antibacterial activities compared to the initial chitosan. The half maximal effective concentration (EC50) of the CHOS fractions were found to be in the range of 2.69–0.724 mg/mL significantly lower than the chitosan (7.75, mg/mL). Besides, the CHOS fractions exhibited lower minimum inhibitory concentration (MIC; in the range of 62.5–500 µg/mL) compared to the initial chitosan (>1000 µg/mL). Moreover, the 3T3-Ll fibroblast cells treated with CHOS fractions exhibited more than 95% viability after 48 h of culture. Cell migration and collagen production assays also showed the positive effect of CHOS fractions, particularly CHOS 3. These results indicate that CHOS can be a promising bioactive agent in biomedical applications, in particular for wound healing applications. |
IMIS is ontwikkeld en wordt gehost door het VLIZ.
